Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Becker, Frank ^a,h,j   Junker, Kerstin ^a,i,j   Parr, Martin ^a,j   Hartmann, Arndt ^b,j   Füssel, Susanne ^c,j   Toma, Marieta ^c,j   Grobholz, Rainer ^d   Pflugmann, Thomas ^e   Wullich, Bernd ^b,j   Strauss, Arne ^f,j   Behnes, Carl Ludwig ^f,j   Otto, Wolfgang ^g,j   Stöckle, Michael ^a,j   Jung, Volker ^a,j  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Kantonsspital Aarau ^*  (Switzerland)

^e St Franziskus Clinics   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY OF REGENSBURG   (Germany)

^h Boxberg Centre   (Germany)

ⁱ JENA UNIVERSITY HOSPITAL   (Germany)

^j For the German Network of Renal Cell Tumors   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COLLECTING DUCT CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION; URINARY TRACT CARCINOMA; CLINICAL TRIAL; GENETICS; HUMAN CHROMOSOME; KIDNEY TUMOR; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED;

EID: 84886033962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078137     Document Type: Article

References (34)

1. Fleming S, Lewi HJ, (1986) Collecting duct carcinoma of the kidney. Histopathology 10: 1131-1141. doi:10.1111/j.1365-2559.1986.tb02553.x. PubMed: 3542784.
2. Dimopoulos MA, Logothetis CJ, Markowitz A, Sella A, Amato R, et al. (1993) Collecting duct carcinoma of the kidney. Br J Urol 71: 388-391. doi:10.1111/j.1464-410X.1993.tb15978.x. PubMed: 8499979.
3. Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, et al. (1990) Collecting duct carcinoma of the kidney. Hum Pathol 21: 449-456. doi:10.1016/0046-8177(90)90209-N. PubMed: 2318486.
4. Carter MD, Tha S, McLoughlin MG, Owen DA, (1992) Collecting duct carcinoma of the kidney: a case report and review of the literature. J Urol 147: 1096-1098. PubMed: 1552595.
5. Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, et al. (2007) Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study. J Urol 177: 1698-1702. doi:10.1016/j.juro.2007.01.063. PubMed: 17437788.
6. Wright JL, Risk MC, Hotaling J, Lin DW, (2009) Effect of collecting duct histology on renal cell cancer outcome. J Urol 182: 2595-2599. doi:10.1016/j.juro.2009.08.049. PubMed: 19836761.
7. Abern MR, Tsivian M, Polascik TJ, Coogan CL, (2012) Characteristics and outcomes of tumors arising from the distal nephron. Urology 80: 140-146. doi:10.1016/j.urology.2012.03.034. PubMed: 22626576.
8. May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, et al. (2013) Impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma- Development of a disease-specific risk-model. J Urol.
9. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, et al. (2006) Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol 176: 40-43; discussion: 10.1016/S0022-5347(06)00502-7. PubMed: 16753362.
10. Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, et al. (2007) Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol 52: 1140-1145. doi:10.1016/j.eururo.2007.01.070. PubMed: 17336449.
11. Füzesi L, Cober M, Mittermayer C, (1992) Collecting duct carcinoma: cytogenetic characterization. Histopathology 21: 155-160. doi:10.1111/j.1365-2559.1992.tb00364.x. PubMed: 1505933.
12. Schoenberg M, Cairns P, Brooks JD, Marshall FF, Epstein JI, et al. (1995) Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer 12: 76-80. doi:10.1002/gcc.2870120115. PubMed: 7534117.
13. Verdorfer I, Culig Z, Hobisch A, Bartsch G, Hittmair A, et al. (1998) Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisation. Int J Oncol 13: 461-464. PubMed: 9683779.
14. Orsola A, Trias I, Raventós CX, Español I, Cecchini L, et al. (2005) Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. Urology 65: 49-54. doi:10.1016/j.urology.2004.08.012. PubMed: 15667862.
15. Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, et al. (2010) PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 34: 965-969. doi:10.1097/PAS.0b013e3181dc5e8a. PubMed: 20463571.
16. Carvalho JC, Thomas DG, McHugh JB, Shah RB, Kunju LP, (2012) p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology 60: 597-608. doi:10.1111/j.1365-2559.2011.04093.x. PubMed: 22260386.
17. Kafé H, Verbavatz JM, Cochand-Priollet B, Castagnet P, Vieillefond A, (2004) Collecting duct carcinoma: an entity to be redefined? Virchows Arch 445: 637-640. doi:10.1007/s00428-004-1124-z. PubMed: 15480763.
18. Staehler M, Schöppler G, Haseke N, Stadler T, Karl A, et al. (2009) Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib. Clin Genitourin Cancer 7: 58-61. doi:10.3816/CGC.2009.n.025. PubMed: 19213670.
19. Jung V, Wullich B, Kamradt J, Stockle M, Unteregger G, (2007) An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations. Toxicol In Vitro 21: 183-190. doi:10.1016/j.tiv.2006.09.021.
20. Jung V, Romeike BF, Henn W, Feiden W, Moringlane JR, et al. (1999) Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58: 993-999. doi:10.1097/00005072-199909000-00009. PubMed: 10499441.
21. Singh I, Nabi G, (2002) Bellini duct carcinoma: review of diagnosis and management. Int Urol Nephrol 34: 91-95. doi:10.1023/A:1021315130481. PubMed: 12549647.
22. Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, et al. (2003) Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma? J Urol 169: 1287-1290. doi:10.1097/01.ju.0000050221.51509.f5. PubMed: 12629344.
23. Parker R, Reeves HM, Sudarshan S, Wolff D, Keane T, (2005) Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology 66: 1110. PubMed: 16286148.
24. Gregori-Romero MA, Morell-Quadreny L, Llombart-Bosch A, (1996) Cytogenetic analysis of three primary Bellini duct carcinomas. Genes Chromosomes Cancer 15: 170-172. doi:10.1002/(SICI)1098-2264(199603)15:3. PubMed: 8721681.
25. Cavazzana AO, Prayer-Galetti T, Tirabosco R, Macciomei MC, Stella M, et al. (1996) Bellini duct carcinoma. A clinical and in vitro study. Eur Urol 30: 340-344. PubMed: 8931967.
26. Junker K, Weirich G, Amin MB, Moravek P, Hindermann W, et al. (2003) Genetic subtyping of renal cell carcinoma by comparative genomic hybridization. Recent Results Cancer Res 162: 169-175. doi:10.1007/978-3-642-59349-9_15. PubMed: 12790331.
27. Wilhelm M, Veltman JA, Olshen AB, Jain AN, Moore DH, et al. (2002) Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 62: 957-960. PubMed: 11861363.
28. Marín-Aguilera M, Mengual L, Ribal MJ, Musquera M, Ars E, et al. (2007) Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol 51: 409-415; discussion: 10.1016/j.eururo.2006.08.045. PubMed: 17010508.
29. Fadl-Elmula I, Gorunova L, Mandahl N, Elfving P, Lundgren R, et al. (1999) Cytogenetic analysis of upper urinary tract transitional cell carcinomas. Cancer Genet Cytogenet 115: 123-127. doi:10.1016/S0165-4608(99)00075-8. PubMed: 10598145.
30. Meloni-Ehrig AM, (2002) Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 115: 164-172. doi:10.1002/ajmg.10697. PubMed: 12407697.
31. Girgis AH, Iakovlev VV, Beheshti B, Bayani J, Squire JA, et al. (2012) Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Res 72: 5273-5284. doi:10.1158/1538-7445.AM2012-5273. PubMed: 22926558.
32. Pei J, Feder MM, Al-Saleem T, Liu Z, Liu A, et al. (2010) Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma. Genes Chromosomes Cancer 49: 610-619. PubMed: 20461753.
33. Dondeti VR, Wubbenhorst B, Lal P, Gordan JD, D'Andrea K, et al. (2012) Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets. Cancer Res 72: 112-121. doi:10.1158/1538-7445.AM2012-112. PubMed: 22094876.
34. Misumi T, Yamamoto Y, Miyachika Y, Eguchi S, Chochi Y, et al. (2012) DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma. Cancer Genet 205: 313-318. doi:10.1016/j.cancergen.2012.04.008. PubMed: 22749037.